(Q46371488)

English

Cabergoline decreases somatotroph adenoma size: a case report

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15761660

Cabergoline decreases somatotroph adenoma size: a case report (English)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15761660

author name string

Michael R Rickels

1

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15761660

Peter J Snyder

2

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15761660

publication date

1 January 2004

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15761660

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15761660

7

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15761660

2

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15761660

107-110

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15761660

https://scigraph.springernature.com/pub.10.1007/s11102-005-5353-1

0 references

Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients

1 reference

https://api.crossref.org/works/10.1007%2FS11102-005-5353-1

21 January 2018

Cabergoline in acromegaly: a renewed role for dopamine agonist treatment?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15761660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/15761660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The volume of the sella turcica

1 reference

https://pubmed.ncbi.nlm.nih.gov/15761660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of different dopaminergic agents in the treatment of acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/15761660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin analogs in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/15761660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cabergoline treatment of acromegaly: a preliminary dose finding study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15761660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cabergoline in the treatment of acromegaly: a study in 64 patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15761660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-lasting lowering of serum growth hormone and prolactin levels by single and repetitive cabergoline administration in dopamine-responsive acromegalic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15761660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide treatment of acromegaly. A randomized, multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15761660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide as primary therapy for acromegaly.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15761660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acromegaly with dopamine agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/15761660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15761660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pituitary adenomas secreting large amounts of prolactin may give false low values in immunoradiometric assays. The hook effect

1 reference

https://pubmed.ncbi.nlm.nih.gov/15761660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11102-005-5353-1

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15761660

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/15761660

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46371488&oldid=2108249752"